Successful treatment of non-uremic calciphylaxis with intralesional sodium thiosulfate: A report of two case
Keywords:
sodium thiosulphate, leg ulcers, retiform purpura, thrombotic vasculopathyAbstract
Calciphylaxis is a rare cause of purpura and cutaneous ulceration frequently occurs in patients with end-stage renal failure. To date, there is no approved therapy for the management of this potentially life-threatening thrombotic vasculopathy. We report two cases of non-uremic calciphylaxis successfully treated with intralesional (IL) sodium thiosulfate. A woman in her 50s with underlying diabetes, hypertension, and ischemic stroke was referred to us for painful leg ulcers for 5 months. She was admitted for sepsis with uncontrolled diabetes. Her white blood cell was 10.6 x 103/uL with a C-reactive protein of 36.3 mg/L and her blood culture was negative. Histopathological examination of the ulcer revealed calcium deposition in the walls of the medium-sized vessels in the subcutaneous tissue. Tissue culture grew Sstaphylococcus aureus. Another woman in her 50s with underlying diabetes was admitted for septic shock complicated with acute kidney injury. During her hospitalization, she developed generalised blisters with retiform purpura. The blisters progressively became ulcerated. Histopathological examination of the purpura revealed calcium deposition in the walls of the dermal vessels. We performed IL sodium thiosulfate for these two patients, along with management of the infection. The one-year mortality of calciphylaxis is reported at 45-80% related to sepsis. Intravenous (IV) sodium thiosulfate is the most frequently utilised in the management of this condition owing to its direct vascular inhibitory effects, antioxidant and vasodilatory properties, however, its efficacy has not been studied in controlled trials. IL sodium thiosulfate injection, with or without combination with IV sodium thiosulfate has been reported to be beneficial in case reports among patients with uremic calciphylaxis. Treatment with IL sodium thiosulfate results in the resolution of purpura and healing of cutaneous ulcerations in our patients with non-uremic calciphylaxis. More research is needed to evaluate the efficacy and drug dosing of this novel therapy.
Downloads
Published
How to Cite
Issue
Section
License
Borneo Journal of Medical Sciences
Copyright transfer and contributions agreement to publish in Borneo Journal of Medical Sciences (BJMS)
Transfer our author right to Borneo Journal of Medical Sciences (BJMS Publishers) along with title, interest in article without any limitations. The Journal shall own the work, including 1) copyright; 2) the right to grant permission to republish the article in whole or in part, with or without fee; 3) the right to produce preprints or reprints and translate into languages other than English for sale or free distribution; and 4) the right for electronic/visual reproduction, electronic storage and to republish the work in a collection of articles in any other mechanical or electronic format or printed publications.
We, the authors certify to participate sufficiently in the intellectual content, conception and design of this work or the analysis and interpretation of the data (when applicable), as well as the writing of the manuscript, to take public responsibility for it and have agreed to have our name listed as a contributor. We believe the manuscript represents valid work. Neither this manuscript nor one with substantially similar content under our authorship has been published or is being considered for publication elsewhere, except as described in the covering letter. Any such involvement, publishers of BJMS are not responsible and the authors are held for any untoward practices if any. Any other reproduction of the said article requires the permission from the publisher.
Authors also state that, the work is original and is not infringing with the rights of others and copyrights. Author also further declares that, each co-author have contributed significantly and have accepted to be co-authors for their significant contribution for the work.
We certify that all the data collected during the study is presented in this manuscript and no data from the study has been or will be published separately. We attest that, if requested by the editors, we will provide the data/information or will cooperate fully in obtaining and providing the data/information on which the manuscript is based, for examination by the editors or their assignees.
We give the rights to the corresponding author to make necessary changes as per the request of the journal, do the rest of the correspondence on our behalf and he/she will act as the guarantor for the manuscript on our behalf. All persons who have made substantial contributions to the work reported in the manuscript, but who are not contributors, are named in the Acknowledgment and have given us their written permission to be named. If we do not include an Acknowledgment that means we have not received substantial contributions from non-contributors and no contributor has been omitted.